Stablecoin Development Corp (SDEV) Stock Price, Quote & News

Company Profile

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoi...

Industry: Asset Management

Sector: Financial Services

Phone: 510 899 8800

Fax: 510 474 1577

Website: stabledev.com

Address:

2000 Powell Street, Suite 1150, EmeryVille, United States

888penny Jun. 15 at 8:51 PM

$SDEV placed a small bet at $1.12, see what happens.

0 · Reply

Bazziggr Jun. 15 at 10:21 AM

$SDEV

0 · Reply

BULLETSTOCK Jun. 15 at 8:01 AM

$SDEV + $MASK.X + $VSME WATCH

0 · Reply

ronnieme22 Jun. 13 at 4:11 PM

$YMT $SDEV $YDKG In my list, hope to run soon🤞⬆️

0 · Reply

Robbob79 Jun. 12 at 10:01 PM

$SDEV I bought in last night cause someone said it was going to take off. Ended up selling an hour later at a 15$ loss but a win for not staying

1 · Reply

BULLETSTOCK Jun. 12 at 1:48 PM

$SDEV + $VSME Watch $BYAH was a surprise

0 · Reply

Twobad31 Jun. 12 at 11:53 AM

$SDEV hit 1.50 twice and closed ah at 1.30.. this looks like free money entry here.

0 · Reply

NABBIT Jun. 12 at 5:32 AM

$SDEV yuge bullrun starting today 💥🔥🚀

2 · Reply

STACKD0E Jun. 12 at 3:16 AM

$RKLB $ASTS $SDEV

0 · Reply

NABBIT Jun. 12 at 1:53 AM

$SPCX ✅️ $SDEV ✅️ Quick run down: 1. No debts 2. Operational spendings 150k per year 3. Net income 11 million per year 4. Holded assets 140 million dollars 5. Real per share value 4.50 now 6. Cash amount on hand 21 millions SDEV will tripple any minute! Dyor and step in at the start

0 · Reply

Stablecoin Development Corporation Reports First Quarter 2026 Financial Results

May 20, 2026, 8:30 AM EDT - 26 days ago

Stablecoin Development Quarterly report: Q1 2026

May 20, 2026, 8:30 AM EDT - 26 days ago

Stablecoin Development Earnings release: Q1 2026

Apr 6, 2026, 8:30 AM EDT - 2 months ago

Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”

Mar 23, 2026, 8:30 AM EDT - 3 months ago

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Mar 19, 2026, 7:00 AM EDT - 3 months ago

Stablecoin Development Annual report: Q4 2025

Mar 12, 2026, 2:00 PM EDT - 3 months ago

Stablecoin Development Transcript: EGM 2026

Mar 2, 2026, 7:00 AM EST - 3 months ago

Stablecoin Development Proxy statement: Proxy Filing

Feb 10, 2026, 7:00 AM EST - 4 months ago

Stablecoin Development Proxy statement: Proxy Filing

Jan 30, 2026, 7:00 AM EST - 4 months ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 25, 2025, 7:00 AM EST - 7 months ago

Stablecoin Development Registration statement: Registration Filing

Nov 7, 2025, 4:00 PM EST - 7 months ago

Stablecoin Development Quarterly report: Q3 2025

Oct 20, 2025, 7:07 PM EDT - 8 months ago

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

Oct 9, 2025, 8:00 AM EDT - 8 months ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 3, 2025, 8:00 AM EDT - 9 months ago

Stablecoin Development Registration statement: Registration Filing

Sep 23, 2025, 8:00 AM EDT - 9 months ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 18, 2025, 4:30 PM EDT - 9 months ago

NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

Sep 18, 2025, 8:00 AM EDT - 9 months ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 10, 2025, 8:00 AM EDT - 9 months ago

Stablecoin Development Proxy statement: Proxy Filing

Aug 26, 2025, 4:05 PM EDT - 10 months ago

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

Aug 19, 2025, 5:25 PM EDT - 10 months ago

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Aug 14, 2025, 7:00 AM EDT - 10 months ago

Stablecoin Development Quarterly report: Q2 2025

May 14, 2025, 6:00 PM EDT - 1 year ago

Stablecoin Development Quarterly report: Q1 2025

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Annual report: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 7, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 7, 2025, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Feb 18, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Feb 4, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Jan 23, 2025, 8:00 AM EST - 1 year ago

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Jan 23, 2025, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 19, 2024, 6:50 AM EST - 1 year ago

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Dec 18, 2024, 2:00 PM EST - 1 year ago

Stablecoin Development Transcript: EGM 2024

Dec 11, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 9, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Dec 9, 2024, 6:50 AM EST - 1 year ago

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Nov 26, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 22, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Nov 15, 2024, 8:00 AM EST - 1 year ago

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Nov 15, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 13, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 12, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Nov 7, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:00 PM EST - 1 year ago

Stablecoin Development Quarterly report: Q3 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Nov 6, 2024, 7:00 AM EST - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 29, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC

Oct 29, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Oct 16, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 25, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Sep 20, 2024, 8:30 AM EDT - 1 year ago

Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Sep 20, 2024, 8:00 AM EDT - 1 year ago

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Stablecoin Development Proxy statement: Proxy Filing

Aug 13, 2024, 4:30 PM EDT - 1 year ago

Stablecoin Development Earnings Call Transcript: Q2 2024

Aug 13, 2024, 4:30 PM EDT - 1 year ago

Stablecoin Development Quarterly report: Q2 2024

Aug 13, 2024, 4:05 PM EDT - 1 year ago

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Jul 30, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

Jul 29, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

Jul 26, 2024, 8:30 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

Jul 25, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 16, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 11, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Jul 10, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jul 1, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jun 28, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions

Jun 21, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Registration statement: Registration Filing

Jun 7, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American

May 29, 2024, 5:22 PM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates

May 13, 2024, 8:30 AM EDT - 2 years ago

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings release: Q1 2024

May 9, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon

May 3, 2024, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024

Apr 22, 2024, 6:57 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales

Apr 19, 2024, 6:00 PM EDT - 2 years ago

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Apr 17, 2024, 6:59 AM EDT - 2 years ago

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Apr 8, 2024, 8:00 AM EDT - 2 years ago

Stablecoin Development Proxy statement: Proxy Filing

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings Call Transcript: Q4 2023

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Earnings release: Q4 2023

Mar 26, 2024, 4:30 PM EDT - 2 years ago

Stablecoin Development Annual report: Q4 2023

Mar 26, 2024, 4:05 PM EDT - 2 years ago

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results

Mar 25, 2024, 6:38 PM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024

Mar 14, 2024, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

Jan 30, 2024, 9:00 AM EST - 2 years ago

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales

Jan 9, 2024, 9:15 AM EST - 2 years ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

SNOA

Dec 6, 2023, 6:50 AM EST - 2 years ago

NovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes

Nov 9, 2023, 4:30 PM EST - 2 years ago

Stablecoin Development Earnings Call Transcript: Q3 2023

Nov 9, 2023, 4:30 PM EST - 2 years ago

Stablecoin Development Quarterly report: Q3 2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results

Nov 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Oct 11, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs

Oct 2, 2023, 6:50 AM EDT - 2 years ago

NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference

Sep 14, 2023, 8:00 AM EDT - 2 years ago

NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft

Sep 11, 2023, 8:00 AM EDT - 3 years ago

NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

Aug 10, 2023, 4:30 PM EDT - 3 years ago

Stablecoin Development Earnings Call Transcript: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 3 years ago

Stablecoin Development Quarterly report: Q2 2023

Aug 10, 2023, 4:05 PM EDT - 3 years ago

NovaBay Pharmaceuticals Reports Second Quarter 2023 Financial Results

888penny Jun. 15 at 8:51 PM

$SDEV placed a small bet at $1.12, see what happens.

0 · Reply

Bazziggr Jun. 15 at 10:21 AM

$SDEV

0 · Reply

BULLETSTOCK Jun. 15 at 8:01 AM

$SDEV + $MASK.X + $VSME WATCH

0 · Reply

ronnieme22 Jun. 13 at 4:11 PM

$YMT $SDEV $YDKG In my list, hope to run soon🤞⬆️

0 · Reply

Robbob79 Jun. 12 at 10:01 PM

$SDEV I bought in last night cause someone said it was going to take off. Ended up selling an hour later at a 15$ loss but a win for not staying

1 · Reply

BULLETSTOCK Jun. 12 at 1:48 PM

$SDEV + $VSME Watch $BYAH was a surprise

0 · Reply

Twobad31 Jun. 12 at 11:53 AM

$SDEV hit 1.50 twice and closed ah at 1.30.. this looks like free money entry here.

0 · Reply

NABBIT Jun. 12 at 5:32 AM

$SDEV yuge bullrun starting today 💥🔥🚀

2 · Reply

STACKD0E Jun. 12 at 3:16 AM

$RKLB $ASTS $SDEV

0 · Reply

NABBIT Jun. 12 at 1:53 AM

0 · Reply

NABBIT Jun. 12 at 1:16 AM

$SPCX Giving you lifechanging opportunity Listen up Ticker: ✅️ $SDEV ✅️ Quick run down: 1. No debts 2. Operational spendings 150k per year 3. Net income 11 million per year 4. Holded assets 140 million dollars 5. Real per share value 4.50 now 6. 21 millions cash on hand SDEV will tripple any minute! Dyor and step in at the start

0 · Reply

NABBIT Jun. 12 at 1:15 AM

$SPCX Giving you lifechanging opportunity Listen up Ticker: ✅️ $SDEV ✅️ Quick run down: 1. No debts 2. Operational spendings 150k per year 3. Net income 11 million per year 4. Holded assets 140 million dollars 5. Real per share value 4.50 now 6. 21 millions on hand in cash SDEV will tripple any minute! Dyor and step in at the start

0 · Reply

PSM_EmpowerTrading Jun. 12 at 1:12 AM

🌅📈 Watchlist part 1 part 2 ✅ $PAVS .30 support, if above .45, have potential to .55/.70 📊 ✅ $SDEV 1.20 support, if above 1.55, have potential to 1.80/2.40 📈 ✅ $SPCE low 6 support, if above 6.65, have potential to 7/7.40 🚀 ✅ $KIDZ 1.70 support, if above 2, have potential to 2.50/2.80 📊 🚨 The above tickers are not ideal for swing accumulation at current price 🚨 ✅ Ideal long entry near low current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance 🎯🎯 Goal is GREEN 🤑🤑 not GREED 🥵🥵

0 · Reply

DayTrade_4Life Jun. 12 at 12:25 AM

🔥Some Stocks to Watch for 12 June: SPCX MNTS BYAH EDHL RKTO $OTLK $PAVS $SDEV $SPCE 👉See below info and profile and come join us for Education, Live Alerts, Swings, Strategies, Scanners, Market News.

0 · Reply

topstockalerts Jun. 11 at 11:45 PM

$SDEV this is starting to look like a trend, not just a bounce

1 · Reply

hedgefundoptionsmaster Jun. 11 at 11:45 PM

$INHD $SDEV thanks for the short tip bruh. Gonna short that pos to .25

1 · Reply

Robbob79 Jun. 11 at 11:44 PM

$SDEV what's a good limit price to sell this at if in at 1.18

0 · Reply

StockRookie16 Jun. 11 at 11:41 PM

$SDEV Hopefully this is one of those blast to 6 bucks at 4 am stocks lol

0 · Reply

luminouslumens Jun. 11 at 11:37 PM

$BYAH $RKTO $SDEV $ASTI A few momentum tickers to keep an eye on premarket tomorrow

0 · Reply

NABBIT Jun. 11 at 11:36 PM

$MMA Ticker: ✅️ $SDEV ✅️ Quick run down: 1. No debts 2. Operational spendings 150k per year 3. Net income 11 million per year 4. Holded assets 140 million dollars 5. Real per share value 4.50 now 6. 21 million dollars cash on hands

0 · Reply

KingOfAtlantis Jun. 11 at 11:29 PM

$SDEV watchhing closely

0 · Reply

NABBIT Jun. 11 at 11:21 PM

$SDEV Will cross 2 dollars at the open ... warned

1 · Reply

Market Cap	27.39M
Revenue (ttm)	0.00
Net Income (ttm)	-22.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	159,400
Avg Vol	300,434
Day's Range	N/A - N/A
Shares Out	27.12M
Stochastic %K	2%
Beta	0.17
Analysts	Strong Buy
Price Target	N/A